FNA diagnosis of rhabdoid meningioma!
😱😳😃

secure-web.cisco.com/1RhzFk4a-t2U0Q…

Growing cancer risks on a warming planet - Nelson - 2024 - Cancer Cytopathology - Wiley Online Library acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Thyroid nodules with DICER1 mutation or PTEN alteration: A comparative cytologic, clinical, and molecular study of 117 FNA cases - Jitpasutham - Cancer Cytopathology - Wiley Online Library acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… WC Faquin, MD, PhD Maria Gubbiotti Vania Nosé, MD, PhD Penn Path & Lab Medicine

New! DICER1 and PTEN FNAs reveal many cytologic similarities. DICER1 patients are younger, and PTEN patients had multinodular disease. Awareness of these genetic cohorts can identify patients at risk for thyroid cancer.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

WC Faquin, MD, PhD Zubair Baloch #CytoPath

DICER1 and PTEN 😃😃😃😃

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Read our March issue! 📘

acsjournals.onlinelibrary.wiley.com/toc/19346638/2…

In this issue:
🔹 Mark CC Chen, M.D. FIAC et al on small-volume biopsy of follicular lymphoma
🔹 Andrew A. Renshaw MD and Martha B. Pitman,MD on ROM in renal biopsy
🔹 Chris VandenBussche et al on urine cytology in the detection of RCCs

#cytopath

February's CytoSource focuses on heightened (but variable) #COVID19 risks for pats w/ cancer. Multiple studies have underscored cancer-associated dangers while reaffirming the protective effects of #vaccination & other prevention strategies.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

Bryn Nelson

Recruitment and retention woes, a lack of sustained investment, and partisan harassment and attacks are creating a mounting crisis for public health efforts, including cancer prevention.

Read the latest CytoSource: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn…

Bryn Nelson
@billfaquin

And cases falling in other categories are fast tracked to the weekly tumour board (multidisciplinary meeting, MDM) for early intervention including diagnostic excision #cytochat

For difficult mucinous lesions, we resort to core biopsy (or a good repeat CB) and get MAML2 molecular testing to help evaluate for mucoepidermoid carcinoma. #cytochat

What are the most common immunostains that you use for SG? For us, it is probably PLAG1, HMGA2, and Mammaglobin, NR4A3, and androgen receptor #cytochat

Great review for the #MilanSystem #CytoChat

The Milan System update article was jointly published by Cancer Cytopathology, JASC, and Cytopathology... a nice collaborative effort! #cytochat

Today’s chat focuses on the 2nd edition of the #MilanSystem , which published in July 2023. Revisit the review authored by Milan System experts that summarizes the key updates from each chapter of the 2nd edition: acsjournals.onlinelibrary.wiley.com/doi/10.1002/cn… #CytoChat

Hi - I'm Bill from MGH... happy to be here participating! #cytochat

Can't wait to discuss SG FNA and Milan #cytochat

Looking forward to this dynamic conference with the MGH Head and Neck team! #mghpath

Today’s the day! Join our #CytoChat at 11am EST for an exciting discussion of the 2nd edition of the #MilanSystem for Reporting Salivary Gland #CytoPath . Engage with co-founders WC Faquin, MD, PhD, Esther Diana Rossi, and special guests Zubair Baloch, Güliz Akdaş Barkan, Philippe Vielh, and more.

Ready to go🎊🎊🎉🎉

New CytoSource: our 2nd of a 2-part series examines the struggle to balance preventive care costs vs. benefits, and the lessons of #thyroid cancer overdiagnosis and overtreatment.

acsjournals.onlinelibrary.wiley.com/doi/full/10.10…

@seattlebryn
WC Faquin, MD, PhD